Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) EBIAT: 2010-2021

Historic EBIAT for Neurocrine Biosciences (NBIX) over the last 12 years, with Sep 2021 value amounting to $22.5 million.

  • Neurocrine Biosciences' EBIAT rose 139.06% to $22.5 million in Q3 2021 from the same period last year, while for Sep 2021 it was $444.8 million, marking a year-over-year increase of 376.23%. This contributed to the annual value of $407.3 million for FY2020, which is 1000.81% up from last year.
  • Per Neurocrine Biosciences' latest filing, its EBIAT stood at $22.5 million for Q3 2021, which was down 46.81% from $42.3 million recorded in Q2 2021.
  • Neurocrine Biosciences' EBIAT's 5-year high stood at $347.9 million during Q4 2020, with a 5-year trough of -$102.1 million in Q1 2019.
  • In the last 3 years, Neurocrine Biosciences' EBIAT had a median value of $37.4 million in 2020 and averaged $49.2 million.
  • As far as peak fluctuations go, Neurocrine Biosciences' EBIAT crashed by 306.59% in 2017, and later surged by 967.58% in 2019.
  • Quarterly analysis of 5 years shows Neurocrine Biosciences' EBIAT stood at $6.9 million in 2017, then surged by 162.23% to $18.1 million in 2018, then soared by 88.07% to $34.0 million in 2019, then soared by 923.24% to $347.9 million in 2020, then soared by 139.06% to $22.5 million in 2021.
  • Its last three reported values are $22.5 million in Q3 2021, $42.3 million for Q2 2021, and $32.1 million during Q1 2021.